The potential of urine for human papillomavirus-related cervical cancer prevention

被引:3
作者
Lamsisi, Maryame [1 ]
Li, Guorong [2 ]
Chauleur, Celine [3 ]
Ennaji, Moulay Mustapha [1 ]
Bourlet, Thomas [4 ,5 ]
机构
[1] Hassan II Univ Casablanca, Fac Sci & Tech Mohammedia, Team Virol Oncol & Med Biotechnol, Lab Virol Microbiol Qual & Biotechnol ETB, Mohammadia 20650, Morocco
[2] CHU St Etienne, North Hosp, Dept Urol, Biol Pathol Lab, F-42000 St Etienne, France
[3] CHU St Etienne, North Hosp, Dept Gynecol & Obstet, F-42000 St Etienne, France
[4] Univ Hosp St Etienne, Dept Infect Agents & Hyg, F-42000 St Etienne, France
[5] Univ Lyon, Univ St Etienne, Ctr Int Rech Infectiol,CNRS, GIMAP Team 15,Inserm,U1111,CNRS,UMR5308, F-42000 St Etienne, France
关键词
cervical cancer; gene methylation; HPV; HPV antibodies; non-coding RNAs; prevention; screening; urine; vaccination; RISK HUMAN-PAPILLOMAVIRUS; LONG NONCODING RNAS; HPV DNA; METHYLATION ANALYSIS; SELF-SAMPLES; FOLLOW-UP; WOMEN; COLLECTION; IMPACT; VACCINATION;
D O I
10.2217/fvl-2021-0246
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Plain language summary The global strategy of cervical cancer elimination from the world includes regular screening of women for the detection of treatable precancer. The conventional screening method relies on a cervical sample that is taken by a clinician in a health facility to detect the human papillomavirus (the virus that causes cervical cancer) and to investigate the presence of abnormal cells (that might lead to cancer). Current efforts to generalize cervical screening and encourage women to participate include the alternative of detecting human papillomavirus in urinary samples. In this article, we discuss the potential of this alternative and its challenges. Cervical cancer is one of the most preventable cancers. The introduction of human papillomavirus (HPV) vaccines and the adaptation of regular screening programs are key actions that need to be generalized globally to achieve the goal of cervical cancer elimination. However, it is still challenging to achieve satisfactory coverage rate, and many women are reluctant to participate in gynecologic examination. In this article, we review the research on the application of HPV detection in urine samples for cervical cancer screening and vaccine monitoring, as well as discuss the technical challenges and new technological advancements in urine-based tests. HPV detection in urine is an excellent noninvasive alternative that is widely accepted by women, relatively affordable, and provides the potential to reach women without the necessity for clinical visits. Thus, it is an attractive tool for both cervical cancer screening and vaccine monitoring.
引用
收藏
页码:495 / 508
页数:14
相关论文
共 88 条
[11]   Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries [J].
Brisson, Marc ;
Kim, Jane J. ;
Canfell, Karen ;
Drolet, Melanie ;
Gingras, Guillaume ;
Burger, Emily A. ;
Martin, Dave ;
Simms, Kate T. ;
Benard, Elodie ;
Boily, Marie-Claude ;
Sy, Stephen ;
Regan, Catherine ;
Keane, Adam ;
Caruana, Michael ;
Nguyen, Diep T. N. ;
Smith, Megan A. ;
Laprise, Jean-Francois ;
Jit, Mark ;
Alary, Michel ;
Bray, Freddie ;
Fidarova, Elena ;
Elsheikh, Fayad ;
Bloem, Paul J. N. ;
Broutet, Nathalie ;
Hutubessy, Raymond .
LANCET, 2020, 395 (10224) :575-590
[12]   A Randomized Comparison of Different Vaginal Self-sampling Devices and Urine for Human Papillomavirus Testing-Predictors 5.1 [J].
Cadman, Louise ;
Reuter, Caroline ;
Jitlal, Mark ;
Kleeman, Michelle ;
Austin, Janet ;
Hollingworth, Tony ;
Parberry, Anna L. ;
Ashdown-Barr, Lesley ;
Patel, Deepali ;
Nedjai, Belinda ;
Lorincz, Attila T. ;
Cuzick, Jack .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (04) :661-668
[13]   Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes [J].
Carnalla, Martha ;
Torres-Ibarra, Leticia ;
Barrientos-Gutierrez, Tonatiuh ;
Cruz-Valdez, Aurelio ;
Munoz, Nubia ;
Herrero, Rolando ;
Stanley, Margaret ;
Nyitray, Alan ;
Salmeron, Jorge ;
Lazcano-Ponce, Eduardo .
VACCINE, 2021, 39 (32) :4419-4422
[14]   MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy [J].
Causin, Rhafaela L. ;
da Silva, Luciane S. ;
Evangelista, Adriane F. ;
Leal, Leticia F. ;
Souza, Karen C. B. ;
Pessoa-Pereira, Danielle ;
Matsushita, Graziela M. ;
Reis, Rui M. ;
Fregnani, Jose H. T. G. ;
Marques, Marcia M. C. .
BIOMED RESEARCH INTERNATIONAL, 2021, 2021
[15]   Mass Spectrometric Analysis of Urine from COVID-19 Patients for Detection of SARS-CoV-2 Viral Antigen and to Study Host Response [J].
Chavan, Sandip ;
Mangalaparthi, Kiran K. ;
Singh, Smrita ;
Renuse, Santosh ;
Vanderboom, Patrick M. ;
Madugundu, Anil Kumar ;
Budhraja, Rohit ;
McAulay, Kathrine ;
Grys, Thomas E. ;
Rule, Andrew D. ;
Alexander, Mariam P. ;
O'Horo, John C. ;
Badley, Andrew D. ;
Pandey, Akhilesh .
JOURNAL OF PROTEOME RESEARCH, 2021, 20 (07) :3404-3413
[16]  
Cho HW, 2021, CANCER RES TREAT, V53, P829, DOI [10.4143/crt.2020.1165, 10.4143/crt.2020.1165CancerResTreat.2021
[17]  
53]
[18]   Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay [J].
Cho, Hyun-Woong ;
Ouh, Yung-Taek ;
Hong, Jin Hwa ;
Min, Kyung Jin ;
So, Kyeong A. ;
Kim, Tae Jin ;
Paik, E. Sun ;
Lee, Jeong-Won ;
Moon, Jun Hye ;
Lee, Jae Kwan .
JOURNAL OF VIROLOGICAL METHODS, 2019, 269 :77-82
[19]   Urine Testing as a Surveillance Tool to Monitor the Impact of HPV Immunization Programs [J].
Cuschieri, Kate ;
Nandwani, Rak ;
McGough, Pauline ;
Cook, Fiona ;
Hogg, Lesley ;
Robertson, Chris ;
Cubie, Heather .
JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (11) :1983-1987
[20]   Urine HPV in the Context of Genital and Cervical Cancer Screening-An Update of Current Literature [J].
Daponte, Alexandros ;
Michail, George ;
Daponte, Athina-Ioanna ;
Daponte, Nikoletta ;
Valasoulis, George .
CANCERS, 2021, 13 (07)